EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Lipocalin 2: a double-edged sword in cellular ferroptosis

Zhangrong Xia, Xinmei Su, Lvsha Xie, Zixian Zhang, Yuanmin He

Cell Biology and Toxicology · 2026

DOI: 10.1007/s10565-026-10145-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Zhangrong Xia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, China. Hauptthemen laut MEDLINE: Ferroptosis, Lipocalin-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Luzhou Municipality, Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a novel form of programmed cell death that is distinct from apoptosis, necrosis, and autophagy (macroautophagy). It is characterized by alterations in intracellular iron levels and lipid peroxidation. Considering its close association with numerous diseases, the molecular mechanisms underlying cellular ferroptosis have recently emerged as a prominent research focus. Lipocalin 2 (LCN2) is a circulating protein involved in the regulation of diverse cellular processes in eukaryotes and is closely associated with ferroptosis. However, the modulation of ferroptosis by LCN2 exhibits significant tissue and disease specificity. This is not only attributed to the ability of LCN2 to mediate iron metabolism reprogramming, but also to its capacity to bidirectionally regulate oxidative stress and interact with multiple signaling pathways. Therefore, this review summarizes the mechanisms through which LCN2 contributes to ferroptosis and its tissue- and disease-specific regulatory functions. Additionally, the current status of the clinical translation of LCN2 as a biomarker and therapeutic target is explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisLipocalin-2HumansAnimalsIronOxidative StressSignal TransductionLipid PeroxidationBiomarkers

Stichwörter der Autor:innen

BiomarkerFerroptosisLipocalin 2SpecificityTherapeutic potential

Substanzen

Lipocalin-2IronLCN2 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, China.
  • Skin Structure and Function Key Laboratory of Luzhou, Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, China.
  • Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, China. heym88@163.com.
  • Skin Structure and Function Key Laboratory of Luzhou, Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, China. heym88@163.com.

Förderung

  • Science and Technology Program of Luzhou Municipality
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Xia, Z., Su, X., Xie, L., Zhang, Z., & He, Y. (2026). Lipocalin 2: a double-edged sword in cellular ferroptosis. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10145-8

Vancouver

Xia Z, Su X, Xie L, Zhang Z, He Y. Lipocalin 2: a double-edged sword in cellular ferroptosis. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10145-8

BibTeX
@article{Xia2026,
  author = {Xia, Zhangrong and Su, Xinmei and Xie, Lvsha and Zhang, Zixian and He, Yuanmin},
  title = {Lipocalin 2: a double-edged sword in cellular ferroptosis},
  journal = {Cell Biology and Toxicology},
  year = {2026},
  doi = {10.1007/s10565-026-10145-8}
}
Kostenlos starten →